Theramex signs exclusive licensing and supply rights deal with TherapeuticsMD

This article was originally published here

As per the terms of the deal, Theramex will have exclusive commercialisation rights for BIJUVA and IMVEXXY outside the US with the exception of Canada and Israel where

The post Theramex signs exclusive licensing and supply rights deal with TherapeuticsMD appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply